Cryo-Cell International, Inc. Cryo-Cell International, Inc.

Cryo-Cell International, Inc.

CCEL

Rank in Stocks #23207
Cryo-Cell International, Inc. engages in cord blood and cord tissue... Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Share Price
$5.40
Last synced: 2026-11-12
Market Cap
$43.54M
Change (1 day)
5.06%
Change (1 year)
33.00%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Cryo-Cell International, Inc. (CCEL)

Category

Healthcare
Earnings for Cryo-Cell International, Inc. (CCEL)
Earnings in Aug 2026 TTM: $-1.91M
According to Cryo-Cell International, Inc.'s latest financial reports, its current earnings (TTM) are $-1.91M. In 2025 the company earned $-2.34M, a decrease compared to its 2024 earnings of $2.80M. The earnings shown on this page are earnings before interest and taxes, or EBIT.
Earnings history for Cryo-Cell International, Inc. from 2000 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $-1.91M -18.34%
2025 $-2.34M -183.35%
2024 $2.80M -120.98%
2023 $-13.36M -502.67%
2022 $3.32M 27.10%
2021 $2.61M -48.18%
2020 $5.04M 48.59%
2019 $3.39M -6.25%
2018 $3.62M -0.17%
2017 $3.62M -246.10%
2016 $-2.48M -361.21%
2015 $949.52K 40.22%
2014 $677.15K 243.70%
2013 $197.02K -104.46%
2012 $-4.42M 160.54%
2011 $-1.70M -195.28%
2010 $1.78M 15.14%
2009 $1.55M -303.38%
2008 $-760.42K -84.81%
2007 $-5.01M 83.54%
2006 $-2.73M -344.11%
2005 $1.12M -62.99%
2004 $3.02M -140.14%
2003 $-7.52M 45.58%
2002 $-5.17M -765.76%
2001 $775.95K -148.19%
2000 $-1.61M 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$9.82B -514,815.75%
US
$2.47B -129,776.29%
DE
$4.73B -248,052.25%
US
$714.40M -37,534.03%
SA
$964.98M -50,663.91%
MY

Questions about Cryo-Cell International, Inc.'s net income

What is Cryo-Cell International, Inc.'s net income?

Cryo-Cell International, Inc.'s net income over the last twelve months is $-1.91M, as of Aug 2026.

What was Cryo-Cell International, Inc.'s net income in 2025?

In 2025, Cryo-Cell International, Inc.'s net income was $-2.34M, compared with $2.80M in 2024.

How has Cryo-Cell International, Inc.'s net income changed since 2020?

From 2020 to 2025, Cryo-Cell International, Inc.'s net income was highest in 2020 ($5.04M) and lowest in 2023 ($-13.36M).

How does Cryo-Cell International, Inc.'s net income compare with similar companies?

Cryo-Cell International, Inc.'s net income ($-1.91M) is lower than that of all 5 similar companies listed above. The highest among them is HCA Healthcare, Inc., with $9.82B.